Concepedia

Dobrochna Dolicka

DD

Statistics

Publications

6

Citations

214

H-Index

6

Active since

2018

Affiliations

University of Geneva(Current)

Postgraduate School of Molecular Medicine

University Hospital of Geneva

University Hospital of Zurich

Jagiellonian University

Dobrochna Dolicka is an author at University of Geneva specializing in molecular oncology, hepatocellular carcinoma pathogenesis, and life sciences.

Publications per year

2018–2022

6

Publications

6

S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development

Cyril Sobolewski, Daniel Abegg, Flavien Berthou et al. · Gut · 2020 · 98 citations · Full text

, , +16

Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis

Marta Correia de Sousa, Nicolas Calo, Cyril Sobolewski et al. · Cancers · 2021 · 39 citations · Full text

, , +17

RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line

Agata Lichawska-Cieślar, Roza Pietrzycka, Janusz Ligęza et al. · Oncotarget · 2018 · 26 citations · Full text

, , +17

Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolism

Dobrochna Dolicka, Natalia Pydyn, Urszula Jankowska et al. · Cellular and Molecular Life Sciences · 2019 · 21 citations · Full text

, , +16

Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy

Dobrochna Dolicka, Cyril Sobolewski, Monika Gjorgjieva et al. · Cellular and Molecular Gastroenterology and Hepatology · 2020 · 17 citations · Full text

, , +17

1–5 of 6